CG

Cristina Ghenoiu

Senior Principal at Mubadala Capital

San Francisco, California

Overview

Work Experience

MC

Mubadala Capital

  • Senior Principal

    2023 - Current

RC

RA Capital Management, L.P.

  • Principal

    2021 - 2023

CB

Capacity Bio

  • Board Director

    2022 - 2023

SM

Superluminal Medicines, Inc.

  • Board Director

    2022 - 2023

RP

Rivus Pharmaceuticals

  • Board Observer & Scientific Co-Founder

    2022 - 2023

GIVAX

  • Board Director

    2021 - 2023

Lusaris

  • Board Director

    2021 - 2022

E

Epirium

  • SVP of R&D Ops. & New Product Planning

    2020 - 2021

    https://epirium.com/

RP

Rivus Pharmaceuticals

  • Board Observer & Scientific Co-Founder

    2019 - 2021

8

89bio

  • Board Observer

    2018 - 2019

Education

Investments

Capacity Bio

Series A

Total Funding: $35M

Relevant Websites